Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis.
Dong Y, Tang BX, Wang Q, Zhou LW, Li C, Zhang X, Sun DD, Sun X, Zhang XM, Xiong B, Li J, Shi H, Chen DQ, Zang Y.
Dong Y, et al. Among authors: li c, li j.
Acta Pharmacol Sin. 2022 Jul;43(7):1769-1779. doi: 10.1038/s41401-021-00808-z. Epub 2021 Nov 24.
Acta Pharmacol Sin. 2022.
PMID: 34819618
Free PMC article.